Author Correction: In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

• Ayele H. Negussie,
• Andrew S. Mikhail,
• Joshua W. Owen,
• Natalie Hong,
• Camella J. Carlson,
• Yiqing Tang,
• Kendal Paige Carrow,
• Michal Mauda-Havakuk,
• Andrew L. Lewis,
• John W. Karanian,
• William F. Pritchard,
• Bradford J. Wood

Affiliations

Ayele H. Negussie

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Andrew S. Mikhail

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Joshua W. Owen

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Natalie Hong

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Camella J. Carlson

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Yiqing Tang

Biocompatibles UK Ltd (a BTG International Group Company)

Kendal Paige Carrow

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Michal Mauda-Havakuk

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Andrew L. Lewis

Biocompatibles UK Ltd (a BTG International Group Company)

John W. Karanian

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

William F. Pritchard

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health

Bradford J. Wood

Center for Interventional Oncology, Radiology and Imaging Sciences, NIH Clinical Center, National Institutes of Health